Old Well Partners’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,438
Closed -$1.49M 32
2024
Q2
$1.49M Sell
10,438
-7,600
-42% -$1.17M 1.63% 23
2024
Q1
$2.82M Buy
18,038
+8,400
+87% +$1.35M 2.38% 18
2023
Q4
$1.74M Sell
9,638
-9,527
-50% -$1.72M 1.54% 24
2023
Q3
$3.45M Sell
19,165
-1,500
-7% -$297K 2.86% 15
2023
Q2
$3.68M Sell
20,665
-19,100
-48% -$4.4M 3.32% 13
2023
Q1
$8.57M Sell
39,765
-2,700
-6% -$648K 6.39% 3
2022
Q4
$9.34M Sell
42,465
-1,800
-4% -$330K 8.08% 2
2022
Q3
$5.97M Buy
44,265
+6,400
+17% +$1.1M 4.96% 8
2022
Q2
$6.13M Buy
37,865
+5,400
+17% +$844K 4.9% 8
2022
Q1
$6.12M Buy
32,465
+2,700
+9% +$574K 4.11% 7
2021
Q4
$8.06M Sell
29,765
-6,300
-17% -$2.13M 4.98% 6
2021
Q3
$13.1M Buy
36,065
+3,500
+11% +$1.14M 6.75% 4
2021
Q2
$11.2M Sell
32,565
-700
-2% -$232K 5.07% 8
2021
Q1
$11.6M Sell
33,265
-13,288
-29% -$4.4M 5.71% 8
2020
Q4
$12M Buy
+46,553
New +$12.8M 6.2% 6

Other funds holding ONC

Old Well Partners's ONC Position: Q3 2024 in Review

Old Well Partners sold out of BeOne Medicines Ltd (ONC) in Q3 2024, closing a stake of 10,438 shares — an estimated $1.49M sold.

Old Well Partners first reported a position in ONC in Q4 2020 and held it in 15 quarters. The position peaked at $13.1M in Q3 2021. 227 funds tracked by Wall St. Rank hold ONC as of Q3 2024.

  • Old Well Partners reported no remaining BeOne Medicines Ltd position as of Q3 2024 after selling out during the quarter.
  • Old Well Partners sold 10,438 BeOne Medicines Ltd shares in Q3 2024, an estimated $1.49M.
  • Old Well Partners first reported a position in BeOne Medicines Ltd in Q4 2020 and held it in 15 quarters.
  • Old Well Partners's BeOne Medicines Ltd position peaked at $13.1M in Q3 2021.
  • 227 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2024.

Based on Old Well Partners's 13F filing for Q3 2024, filed 14 Nov 2024.